Terug
3
Ook genoteerd als
MAURF
OTC
Dagbereik
€ 35,05
€ 40,74
52-Weeksbereik
€ 33,75
€ 45,73
Volume
859
50D / 200D Gem.
€ 40,08
/
€ 40,44
Vorige Slotkoers
€ 37,87
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (854 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 10,3 |
| P/B | 0,0 | 1,1 |
| ROE % | 10,7 | 11,7 |
| Net Margin % | 10,5 | 16,8 |
| Rev Growth 5Y % | 5,4 | 11,7 |
| D/E | 2,6 | 0,5 |
Insider Trading Activity
Buy ratio (90d)
100.0%
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 2026 |
Kotler Arie
Chairman, President and CEO
|
other | 233.603 | — | — |
| Mar 3, 2026 |
Bricks Maury
General Counsel/Secretary
|
other | 56.822 | — | — |
| Mar 3, 2026 |
Nuchamovitz Eyal
See Remarks
|
other | 55.458 | — | — |
| Mar 1, 2026 |
Bricks Maury
General Counsel/Secretary
|
other | 87.812 | — | — |
| Feb 27, 2026 |
Bricks Maury
General Counsel/Secretary
|
grant | 140.921 | — | — |
| Feb 27, 2026 |
Bricks Maury
General Counsel/Secretary
|
other | 17.871 | € 6,43 | € 114.911 |
| Feb 27, 2026 |
Jeff Charles Galagher
Chief Financial Officer, EVP
|
grant | 54.645 | — | — |
| Feb 13, 2026 |
FRIEDMAN AVRAM Z
|
buy | 20.000 | € 18,00 | € 360.000 |
| Jan 2, 2026 |
Fogel Yona
|
grant | 13.484 | — | — |
| Jan 1, 2026 |
Fogel Yona
|
grant | 1.362 | — | — |
| Jan 1, 2026 |
FRIEDMAN AVRAM Z
|
grant | 6.607 | — | — |
| Jan 1, 2026 |
HEYER ANDREW R
|
grant | 7.709 | — | — |
| Dec 11, 2025 |
HEYER STEVEN J
|
other | 156.133 | — | — |
| Oct 1, 2025 |
Edmiston Sherman III
|
grant | 548 | — | — |
| Oct 1, 2025 |
HEYER ANDREW R
|
grant | 7.675 | — | — |
| Oct 1, 2025 |
FRIEDMAN AVRAM Z
|
grant | 5.482 | — | — |
| Jul 1, 2025 |
FRIEDMAN AVRAM Z
|
grant | 5.422 | — | — |
| Jun 5, 2025 |
HEYER STEVEN J
|
grant | 28.473 | — | — |
| Jun 5, 2025 |
HEYER ANDREW R
|
grant | 28.473 | — | — |
| Jun 5, 2025 |
Shapira Karet Laura
|
grant | 28.473 | — | — |
Belangrijkste Punten
Revenue grew 5,40% annually over 5 years — modest growth
ROE of 10,65% — decent returns on equity
Debt/Equity of 2,59 — high leverage
Negative free cash flow of -4,48B
P/E of 0,12 — trading at a low valuation
Capital efficient — spends only 5,15% of revenue on capex
Groei
Revenue Growth (5Y)
5,40%
Revenue (1Y)8,15%
Earnings (1Y)7,79%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
10,65%
ROIC3,78%
Net Margin10,45%
Op. Margin17,50%
Veiligheid
Debt / Equity
2,59
Current Ratio2,67
Interest Coverage12,91
Waardering
P/E Ratio
0,12
P/B Ratio0,01
EV/EBITDA13,26
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,15% | Revenue Growth (3Y) | 8,06% |
| Earnings Growth (1Y) | 7,79% | Earnings Growth (3Y) | 11,27% |
| Revenue Growth (5Y) | 5,40% | Earnings Growth (5Y) | 85,06% |
| Profitability | |||
| Revenue (TTM) | 254,39B | Net Income (TTM) | 26,59B |
| ROE | 10,65% | ROA | 2,52% |
| Gross Margin | 87,56% | Operating Margin | 17,50% |
| Net Margin | 10,45% | Free Cash Flow (TTM) | -4,48B |
| ROIC | 3,78% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,59 | Current Ratio | 2,67 |
| Interest Coverage | 12,91 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 0,12 | P/B Ratio | 0,01 |
| P/S Ratio | 0,01 | PEG Ratio | 2,02 |
| EV/EBITDA | 13,26 | Dividend Yield | 0,04% |
| Market Cap | 3,15B | Enterprise Value | 590,38B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 254,39B | 235,23B | 217,85B | 209,32B | 206,16B |
| Net Income | 26,59B | 24,67B | 21,47B | 17,79B | 2,27B |
| EPS (Diluted) | 286,48 | 261,40 | 218,74 | 171,62 | 21,70 |
| Gross Profit | 222,76B | 205,62B | 191,74B | 181,07B | 177,33B |
| Operating Income | 44,52B | 41,03B | 38,77B | 36,78B | 15,22B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,05T | 1,00T | 961,95B | 920,03B | 901,23B |
| Total Liabilities | 806,72B | 749,88B | 715,38B | 657,97B | 611,13B |
| Shareholders' Equity | 246,14B | 253,25B | 246,15B | 261,61B | 289,58B |
| Total Debt | 636,48B | 594,36B | 584,45B | 528,86B | 486,37B |
| Cash & Equivalents | 49,25B | 64,56B | 52,42B | 39,71B | 41,18B |
| Current Assets | 737,59B | 708,98B | 675,91B | 648,03B | 623,68B |
| Current Liabilities | 276,57B | 245,66B | 258,43B | 266,07B | 221,63B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#614 of 616
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026